• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

International Biotechnology Trust Plc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider SV Life Sciences Managers LLP
Fund Summary The investment objective of International Biotechnology Trust plc (the "Company") is to achieve long-term capital growth by investing primarily in biotechnology and other life sciences companies that are either quoted or unquoted and possess the potential for high growth. The Company invests in companies whose shares are considered to have good prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
SEDOL code 0455934
ISIN GB0004559349
Fund code IBTLL
Managers Ailsa Craig
Manager Tenure 11 years
Morningstar Category Sector Equity Biotechnology
Fund Size £93 million
Fund Type ETF / IT
Management Style Active
Total Expense Ratio (TER) 1.4%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £6.36
Buy Price £6.4
Price Change +1.2739%
Price Date 16th August 2019
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 6th May 1994
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +4.42% +6.15% +23.26% -13.38% +70.79% +23.13% +29.92% +23.97% +12.64% +15.53%
Benchmark Performance
(Sector Equity Biotechnology)
+0.86% +7.59% +19.69% -22.32% +61.96%
Time Period Cumulative Benchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day 0.32% -0.48% +0.79%
1 week -3.05% -0.45% -2.60%
1 month -0.95% +0.44% -1.39%
3 months 4.47% -5.05% +9.51%
6 months 2.17% +0.12% +2.05%
1 year 1.49% -2.15% +3.65%
3 years 39.75% +31.77% +7.98%
5 years 148.84% +65.47% +83.37%
10 years 513.90% +372.96% +140.94%
YTD 14.00% +10.66% +3.33%
Since inception 617.34% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Celgene Corp USA 5.88%
Sv Fund Vi Investment 5.04%
Shire PLC ADR USA 4.74%
Array BioPharma Inc USA 4.45%
Neurocrine Biosciences Inc USA 4.09%
Biogen Inc USA 4.00%
Regeneron Pharmaceuticals Inc USA 3.98%
Genmab A/S DNK 3.86%
Sage Therapeutics Inc USA 3.64%
Vertex Pharmaceuticals Inc USA 3.56%
Dividend Date Per share amount Reinvestment Price
20th December 2018 0.1400 £568.0000
5th January 2017 0.1150 £543.0000